Page last updated: 2024-10-28

phenelzine and Briquet Syndrome

phenelzine has been researched along with Briquet Syndrome in 3 studies

Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.

Research Excerpts

ExcerptRelevanceReference
"The prognosis of treated hypochondriasis is good in a substantial proportion of patients."1.27Functional somatic symptoms and hypochondriasis. A survey of empirical studies. ( Kellner, R, 1985)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gorman, JM1
Kellner, R1
Davidson, J1
Pelton, S1

Trials

1 trial available for phenelzine and Briquet Syndrome

ArticleYear
Forms of atypical depression and their response to antidepressant drugs.
    Psychiatry research, 1986, Volume: 17, Issue:2

    Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Anxiety Disorders; Bupropion; Clinical Trial

1986

Other Studies

2 other studies available for phenelzine and Briquet Syndrome

ArticleYear
Leading the way: advances in the diagnosis, treatment, and management of neuropsychiatric illnesses.
    CNS spectrums, 2006, Volume: 11, Issue:5

    Topics: Administration, Cutaneous; Administration, Topical; Brain; Depressive Disorder, Major; Humans; Menta

2006
Functional somatic symptoms and hypochondriasis. A survey of empirical studies.
    Archives of general psychiatry, 1985, Volume: 42, Issue:8

    Topics: Anti-Anxiety Agents; Attitude to Health; Benzodiazepines; Conditioning, Psychological; Culture; Diag

1985